Correction: A distinct p53 target gene set predicts for response to the selective p53-HDM2 inhibitor NVP-CGM097

Correction: A distinct p53 target gene set predicts for response to the selective p53-HDM2 inhibitor NVP-CGM097

Bibliographic Details
Main Authors:	Sébastien Jeay, Swann Gaulis, Stéphane Ferretti, Hans Bitter, Moriko Ito, Thérèse Valat, Masato Murakami, Stephan Ruetz, Daniel A Guthy, Caroline Rynn, Michael R Jensen, Marion Wiesmann, Joerg Kallen, Pascal Furet, François Gessier, Philipp Holzer, Keiichi Masuya, Jens Würthner, Ensar Halilovic, Francesco Hofmann, William R Sellers, Diana Graus Porta
Format:	Article
Language:	English
Published:	eLife Sciences Publications Ltd 2016-11-01
Series:	eLife
Online Access:	https://elifesciences.org/articles/19317

Similar Items

A distinct p53 target gene set predicts for response to the selective p53–HDM2 inhibitor NVP-CGM097
by: Sébastien Jeay, et al.
Published: (2015-05-01)

NVP-CGM097, an HDM2 Inhibitor, Antagonizes ATP-Binding Cassette Subfamily B Member 1-Mediated Drug Resistance
by: Meng Zhang, et al.
Published: (2020-07-01)

Effect of linker on the binding free energy of stapled p53/HDM2 complex.
by: Haeri Im, et al.
Published: (2020-01-01)

The MDM2 inhibitor CGM097 combined with the BET inhibitor OTX015 induces cell death and inhibits tumor growth in models of neuroblastoma
by: Tyler Maser, et al.
Published: (2020-11-01)

TP53 mutations emerge with HDM2 inhibitor SAR405838 treatment in de-differentiated liposarcoma
by: Joonil Jung, et al.
Published: (2016-08-01)

Activation of cAMP Signaling Interferes with Stress-Induced p53 Accumulation in ALL-Derived Cells by Promoting the Interaction between p53 and HDM2
by: Elin Hallan Naderi, et al.
Published: (2011-07-01)

Characterization and Molecular Mechanism of Peptide-Conjugated Gold Nanoparticle Inhibiting p53-HDM2 Interaction in Retinoblastoma
by: Sushma Kalmodia, et al.
Published: (2017-12-01)

A single nucleotide polymorphism in the HDM-2 gene regulates the p53 apoptotic response and influences the age of onset of cancers in humans: the SNP309HDM-2 polymorphism
by: Bond, G, et al.
Published: (2005)

The p53 tumor suppressor-like protein nvp63 mediates selective germ cell death in the sea anemone Nematostella vectensis.
by: Sandra Pankow, et al.
Published: (2007-09-01)

p14ARF induces the relocation of HDM2 and p53 to extranucleolar sites that are targeted by PML bodies and proteasomes
by: Klein George, et al.
Published: (2003-03-01)

CGM in the real world
by: Mumford, A. M. (Anne M.), 1956-, et al.
Published: (1988)

p53 dynamics vary between tissues and are linked with radiation sensitivity
by: Jacob Stewart-Ornstein, et al.
Published: (2021-02-01)

5S Ribosomal RNA Is an Essential Component of a Nascent Ribosomal Precursor Complex that Regulates the Hdm2-p53 Checkpoint
by: Giulio Donati, et al.
Published: (2013-07-01)

Influence of TP53 Codon 72 Polymorphism Alone or in Combination with HDM2 SNP309 on Human Infertility and IVF Outcome.
by: Ying Chan, et al.
Published: (2016-01-01)

HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (<it>cis</it>-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas
by: Sosin Angela M, et al.
Published: (2012-09-01)

Medium-resolution 0.97–5.3 μm Spectra of Very Young Benchmark Brown Dwarfs with NIRSpec on Board the James Webb Space Telescope
by: Elena Manjavacas, et al.
Published: (2024-01-01)

A single nucleotide polymorphism in the HDM-2 gene regulates the p53 apoptotic response and influences the age of onset of cancers in humans.
by: Levine, A, et al.
Published: (2005)

WIP1 Inhibition by GSK2830371 Potentiates HDM201 through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells
by: Chiao-En Wu, et al.
Published: (2021-07-01)

PNC-27, a Chimeric p53-Penetratin Peptide Binds to HDM-2 in a p53 Peptide-like Structure, Induces Selective Membrane-Pore Formation and Leads to Cancer Cell Lysis
by: Ehsan Sarafraz-Yazdi, et al.
Published: (2022-04-01)

PNC-27, a Chimeric p53-Penetratin Peptide Binds to HDM-2 in a p53 Peptide-like Structure, Induces Selective Membrane-Pore Formation and Leads to Cancer Cell Lysis
by: Sarafraz-Yazdi, Ehsan, et al.
Published: (2022)

PNC-27, a Chimeric p53-Penetratin Peptide Binds to HDM-2 in a p53 Peptide-like Structure, Induces Selective Membrane-Pore Formation and Leads to Cancer Cell Lysis
by: Sarafraz-Yazdi, Ehsan, et al.
Published: (2022)

Ribosomal L1 domain-containing protein 1 coordinates with HDM2 to negatively regulate p53 in human colorectal Cancer cells
by: Li Ding, et al.
Published: (2021-08-01)

Surface Modification of EPR as Biomaterial by Laser Induced Graft Copolymerization of AAm, HEMA and NVP: II- HEMA and NVP
by: H. Mirzadeh, et al.
Published: (1994-09-01)

Long noncoding RNA LINC01088 inhibits esophageal squamous cell carcinoma progression by targeting the NPM1-HDM2-p53 axis
by: Liang Fan, et al.
Published: (2023-03-01)

Modeling of arylamide helix mimetics in the p53 peptide binding site of hDM2 suggests parallel and anti-parallel conformations are both stable.
by: Jonathan C Fuller, et al.
Published: (2012-01-01)

CGM2 + CASBaH: The Mass Dependence of H i Lyα–Galaxy Clustering and the Extent of the CGM
by: Matthew C. Wilde, et al.
Published: (2023-01-01)

Programmed cell death 11 modulates but not entirely relies on p53-HDM2 loop to facilitate G2/M transition in colorectal cancer cells
by: Li Ding, et al.
Published: (2023-12-01)

Impact of a Mobile Application for Tracking Nausea and Vomiting During Pregnancy (NVP) on NVP Symptoms, Quality of Life, and Decisional Conflict Regarding NVP Treatments: MinSafeStart Randomized Controlled Trial
by: Elin Ngo, et al.
Published: (2022-07-01)

The PI3K/mTOR dual inhibitor NVP‐BEZ235 stimulates mutant p53 degradation to exert anti‐tumor effects on triple‐negative breast cancer cells
by: Jiajing Cai, et al.
Published: (2020-04-01)

Authorship Correction: Impact of a Mobile Application for Tracking Nausea and Vomiting During Pregnancy (NVP) on NVP Symptoms, Quality of Life, and Decisional Conflict Regarding NVP Treatments: MinSafeStart Randomized Controlled Trial
by: Elin Ngo, et al.
Published: (2022-09-01)

The 2HDM doppelganger
by: Baradhwaj Coleppa, et al.
Published: (2022-06-01)

Complex Crystal Structure Determination of Hsp90N-NVP-AUY922 and In Vitro Anti-NSCLC Activity of NVP-AUY922
by: Chun-Xia He, et al.
Published: (2022-02-01)

ELC53
Published: (2023-07-01)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
by: Melania Tesio
Published: (2023-02-01)

p53’s Extended Reach: The Mutant p53 Secretome
by: Evangelos Pavlakis, et al.
Published: (2020-02-01)

Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53
by: Lopez, C, et al.
Published: (2000)

The CGM2 Survey: Quenching and the Transformation of the Circumgalactic Medium
by: Kirill Tchernyshyov, et al.
Published: (2023-01-01)

Parkinson Hastalığı ile İlişkilendirilen PreNAC Fibril Kesiti ve Onun A53C, A53E, A53G, A53T, A53V Mutasyonlarının Yapısal Kararlılığın Araştırılması
by: Kadir Demir, et al.
Published: (2021-05-01)

OTUD5 regulates p53 stability by deubiquitinating p53.
by: Judong Luo, et al.
Published: (2013-01-01)

NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity.
by: Fokas, E, et al.
Published: (2012)